Calendar module icon

Calendar

Event Details

Return to Previous

Date:
September 21, 2021
Time:
7:30 PM - 8:30 PM
Location:

Streaming online through NASA Langley

Address:
https://colloqsigma.larc.nasa.gov/
Hampton, VA
Cost:
Free
sigma - amina zeidan
Facebook Twitter Email

Sigma Series -- The Gut Microbiome: Implications for Health on Earth and in Space

Tuesday, September 21, 2021

Each human hosts a microbiome in their gut that is home to more than 1,000 species of bacteria, archaea, viruses, and eukaryotic microbes. These gut microorganisms are highly involved in numerous metabolic reactions that influence normal host physiology and metabolism. Additionally, an enormous portion of the body’s immune function is positioned in the human gut. This means that the bacteria living in your gastrointestinal tract play numerous roles in maintaining your health. Specifically, the health of your gut can influence your risk of cardiovascular disease, cancer, and the development of neurodegenerative diseases, such as dementia. This week's speaker, Amina Zeidan, Ph.D., is a research fellow with NASA Langley’s Space Radiation Risk Research Group. As a translational scientist, she conducts research on the human gut microbiome and gut responses to infectious diseases, environmental exposures, and stressful environments, such as those experienced by astronauts.

What is the relevance of the gut microbiome to human health and astronauts? There are several stressors of space travel, including: microgravity, radiation exposure, isolation, anxiety, sleep deprivation, and isolation from medical care, all of which can potentially negatively impact the gut, and therefore, impact overall human health. With several unknowns regarding how these changes can alter human health in the long-term, it is critical for researchers to further their understanding of space travel stressors effects on the gut microbiome so that we may ensure the health and safety of our astronauts during mission time and after their return home. 

Dr. Zeidan has presented her research both nationally and internationally, notably being a returning presenter at the European Congress of Clinical Microbiology & Infectious Diseases. Some of her previous work has focused on the response of the human gut microbiome to Clostridioides difficile infection, the recovery process, and short- and long-term health outcomes associated with infection. A native Missourian, she received her B.S. from George Mason University (Community Health & Preventive Medicine), two master of public health degrees from the University of South Florida College of Public Health (Epidemiology & Global Communicable Diseases), and her Ph.D. from the University of Texas at Austin and UT Health Science Center at San Antonio (Translational Science). She is currently board certified by the National Board of Public Health Examiners. Dr. Zeidan is adjunct faculty at George Mason University in Fairfax, Virginia, and guest lectures for public health courses at several colleges and universities.